Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ATYR THE BIO BEST ODF WALLSTREET
ATYR WE ARE OFF
AYTR GAPPING HARD NOW
Agree. This one started running early - still plenty of time till the ph3 readout in q3 25.
See September 13 2021... 12$ on the ph1b/2a data. So i believe some more than that some day.
WAITING ON THE 4 HOUR
CONSOLIDATION ALMOST OVER
CONSOLIDATION ALMOST OVER
check this out: Efzofitimod vs SOC....... 50% drop out the SOC is so bad, people prefer no treatment.
TAM 17bn
https://www.imarcgroup.com/pulmonary-sarcoidosis-market
to the finish line....
ATYR.......................................https://stockcharts.com/h-sc/ui?s=ATYR&p=W&b=5&g=0&id=p86431144783
ATYR...BREAK ON THE WEEKLY..A BIT A HEAD OF ITSELF...BUT MONTHLY HAS ROOM
super action
Point 72 buying common stock... Can you believe it?
SEE THIS: 54.4% of patients in the subtherapeutic group relapsed following corticosteroid taper, compared to 7.7% in the therapeutic group.
The cure for this horrible disease is so bad, half the people chose cholera over plague...
running towards PH3 interstitial lung disease / sarcoidosis -- SOC are corticosteroids that RUINS people
Paul Schimmel .... founder and godfather of tRNA synthetases owns 400k shares a big chunk of that was bought earlier this summer
all coming together soon
"post hoc analysis of Phase 1b/2a study demonstrated statistically significant difference in time-to-first-relapse for corticosteroid use in therapeutic (3.0 and 5.0 mg/kg efzofitimod) vs subtherapeutic (1.0 mg/kg efzofitimod and placebo) groups.
54.4% of patients in the subtherapeutic group relapsed following corticosteroid taper, compared to 7.7% in the therapeutic group.
ATYR................................https://stockcharts.com/h-sc/ui?s=ATYT&p=W&b=5&g=0&id=p86431144783
Nice !
We ended 2023 with more than $100 million in cash, restricted cash, cash equivalents and investments. Based on our current cash position and operational plans, we believe our financial resources are sufficient to fund the Company’s operations through the filing of a Biologics License Application (BLA) for efzofitimod in pulmonary sarcoidosis."
$LIFE
Top Meme Stock Mentions Money to Move 12/30/2021
$LIFE: $20M
Money to Move is a proprietary estimate of the total added monetary volume required to move a stock based on float liquidity and short percentage. Updated daily for high social interest stocks.
See more... https://gravityanalyticaresearch.com https://gravityanalytica.com
Top Meme Stock Mentions Money to Move 12/01/2021
$LIFE: $23M
Money to Move is a proprietary estimate of the total added monetary volume required to move a stock based on float liquidity and short percentage. Updated daily for high social interest stocks.
See more... https://gravityanalyticaresearch.com https://gravityanalytica.com
Top Meme Stock Mentions Money to Move 11/23/2021
$LIFE: $22M
Money to Move is a proprietary estimate of the total added monetary volume required to move a stock based on float liquidity and short percentage. Updated daily for high social interest stocks.
See more... https://gravityanalyticaresearch.com https://gravityanalytica.com
Top Meme Stock Mentions Money to Move 11/03/2021
$LIFE: $24M
Money to Move is a proprietary estimate of the total added monetary volume required to move a stock based on float liquidity and short percentage. Updated daily for high social interest stocks.
See more... https://gravityanalyticaresearch.com https://gravityanalytica.com
Top Meme Stock Mentions Money to Move 11/01/2021
$LIFE: $24M
Money to Move is a proprietary estimate of the total added monetary volume required to move a stock based on float liquidity and short percentage. Updated daily for high social interest stocks.
See more... https://gravityanalyticaresearch.com https://gravityanalytica.com
Top Meme Stock Mentions Money to Move 10/14/2021
$LIFE: $26M
Money to Move is a proprietary estimate of the total added monetary volume required to move a stock based on float liquidity and short percentage. Updated daily for high social interest stocks.
See more... https://gravityanalyticaresearch.com https://gravityanalytica.com
Top Meme Stock Mentions Money to Move 09/17/2021
$LIFE: $17M
Money to Move is a proprietary estimate of the total added monetary volume required to move a stock based on float liquidity and short percentage. Updated daily for high social interest stocks.
See more... https://gravityanalyticaresearch.com https://gravityanalytica.com
LIFE shares are trading higher after multiple firms maintained bullish ratings on the stock and raised their respective price targets.
12.30
LIFE
Top Meme Stock Mentions Money to Move 08/13/2021
$LIFE: $7M
Money to Move is a proprietary estimate of the total added monetary volume required to move a stock based on float liquidity and short percentage. Updated daily for high social interest stocks.
See more... https://gravityanalyticaresearch.com https://gravityanalytica.com
* * $LIFE Video Chart 03-16-2021 * *
Link to Video - click here to watch the technical chart video